STEPHEN BROUGHTON: Open Payments
NPI 1861411167 · PINE BLUFF, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 11 payments from 6 companies in 2025. Trend: 2023 $405 · 2024 $197 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $94 |
| Abbott Laboratories | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Alkermes, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: COBENFY, CARDIOMEMS, CAPLYTA, INGREZZA, LYBALVI, ARISTADA, INVEGA SUSTENNA.
Industry payments across AR — which companies pay providers there.
